EP3617330
BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.3.2012EP published:
27.12.2023EP application number:
19203410.6
EPO information:
European Patent Register
Max expiry date:
29.3.2032
Title in English:
BIOMARKERS FOR PREDICTING SENSITIVITY TO CANCER TREATMENTSLanguage of the patent:
English
Timeline
Today
30.3.2012EP application
27.12.2023EP Publication
Owner
Name:
GENENTECH, INC.Address:
1 DNA Way, South San Francisco, CA 94080-4990, US
Inventor
Name:
LIN, KuiAddress:
South San Francisco, CA California 94080-4990, US
Name:
PUNNOOSE, ElizabethAddress:
South San Francisco, CA California 94080-4990, US
Name:
SESHAGIRI, SomasekarAddress:
South San Francisco, CA California 94080-4990, US
Priority
Number:
201161471036 PDate:
1.4.2011Country:
US
Classification
Categories:
C12Q 1/6886, A61K 31/517, A61K 31/58